Justification for HAIC Changes (Jan 2021)

EIP 0920-0978_Non-sub change request_11232020v2.docx

Emerging Infections Program

Justification for HAIC Changes (Jan 2021)

OMB: 0920-0978

Document [docx]
Download: docx | pdf


Emerging Infections Programs (EIP)

OMB Control Number 0920-0978

Expiration Date: 4/30/2022





Program Contact


Sonja Mali Nti-Berko

Emerging Infections Programs (EIP)

Division of Preparedness and Emerging Infections

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

1600 Clifton Rd, MS-C18

Atlanta, GA 30329

Phone: (404) 488-4780

E-mail: [email protected]



Submission Date: November 23, 2020


Table of Contents and Attachments




  1. Non-Substantive Change Request Justification Document

  2. Description of Changes (Att 1)

  3. Cross-Walk (Att 2)

  4. HAIC: Resistant Gram-Negative Bacilli (MuGSI) Case Report Form for Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii (Att 3)

  5. HAIC: Multi-site Gram-Negative Surveillance Initiative (MuGSI)- Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) (Att. 4)

  6. HAIC: Annual Survey of Laboratory Testing Practices for C. difficile Infections (Att. 5)



Justification for Change Request for OMB 0920-0978


This is a nonmaterial/non-substantive change request for OMB No. 0920-0978, expiration date 05/31/2021, for the Emerging Infections Programs (EIP). All requested changes represent minor modifications to already-approved instruments including revised formatting, rewording, new answer options, and the addition/subtraction of a limited number of questions.


The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions, local health departments, public health and clinical laboratories, infection control professionals, and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases.


Activities of the EIPs fall into the following general categories: (1) active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.


Activities in the EIP Network in which all applicants must participate are:

  • Active Bacterial Core surveillance (ABCs): active population-based laboratory surveillance for invasive bacterial diseases.

  • Foodborne Diseases Active Surveillance Network (FoodNet): active population-based laboratory surveillance to monitor the incidence of select enteric diseases.

  • Influenza Hospitalization Surveillance Network (FluSurv-NET): active population-based surveillance for laboratory confirmed influenza-related hospitalizations.

  • Healthcare-Associated Infections-Community Interface (HAIC) surveillance: active population-based surveillance for healthcare-associated pathogens and infections.


This non-substantive change request is for changes to the disease-specific data elements for only HAIC. The changes made to the all forms under this non-substantive request will aid in improving surveillance efficiency and data quality to clarify the burden of disease and possible risk factors for disease. This information can be used to inform strategies for preventing disease and negative outcomes. Specifically, changes were made for clarification purposes, to assist data collectors in capturing data in a standardized fashion to improve accuracy. As a result of proposed changes, the estimated annualized burden is expected to increase by 11 hours, from 38,883 to 38,894. The data elements and justifications are described below.


The forms for which approval for changes are being sought include:


HAIC:

  • Resistant Gram-Negative Bacilli (MuGSI) Case Report Form for Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii (Attachment 3)

  • 2020 Multi-site Gram-Negative Surveillance Initiative (MuGSI)- Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) (Attachment 4)

  • Annual Survey of Laboratory Testing Practices for C. difficile Infections (Attachment 5)



The changes for Resistant Gram-Negative Bacilli (MuGSI) Case Report Form for Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii (Attachment 3) and

2020 Multi-site Gram-Negative Surveillance Initiative (MuGSI)- Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) (Attachment 4) will be effective and implemented on 01/01/2021. The Annual Survey of Laboratory Testing Practices for C. difficile Infections (Attachment 5) will be administered in 2021.





Estimated Annualized Burden Hours

As a result of proposed changes to forms highlighted in yellow, the estimated annualized burden is expected to increase by11 hours, from 38,883 to 38,894.



The following table is updated for the entire 0920-0978 burden table. The forms included in this change request are highlighted:



Type of Respondent

Form Name

No. of respondents

No. of responses per respondent

(Current)

Avg. burden per response (in hours)

(Current)

Avg. burden per response (in hours)

(After Changes)

Current Proposed Changes

After Proposed Changes

State Health Department


ABCs Case Report Form

10

809

20/60


2697

2697

ABCs Invasive Pneumococcal Disease in Children Case Report Form

10

22

10/60



37


37

ABCs H. influenzae Neonatal Sepsis Expanded Surveillance Form

10

6

10/60


10

10

ABCs Severe GAS Infection Supplemental Form

10

136

20/60


453

453

ABCs Neonatal Infection Expanded Tracking Form

10

37

20/60


123

123

FoodNet Campylobacter

10

970

21/60


3395

3395

FoodNet Cyclospora

10

42

10/60


70

70

FoodNet Listeria monocytogenes

10

16

20/60


53

53

FoodNet Salmonella

10

855

21/60


2993

2993

FoodNet Shiga toxin producing E. coli

10

290

20/60


967

967

FoodNet Shigella

10

234

10/60


390

390

FoodNet Vibrio

10

46

10/60


77

77

FoodNet Yersinia

10

55

10/60


92

92

FoodNet Hemolytic Uremic Syndrome

10

10

1


100

100

FoodNet Clinical Laboratory Practices and Testing Volume

10

70

20/60


233

233

FluSurv-Net

Influenza Hospitalization Surveillance Network Case Report Form

10

977

17/60


2768

2768

FluSurv-Net

Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English)

10

333

5/60


278

278

FluSurv-Net

Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (Spanish)

10

333

5/60


278

278

FluSurv-Net

Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)

10

333

5/60


278

278

FluSurv-NET Laboratory Survey

10

23

10/60


38

38

HAIC - MuGSI Case Report Form for Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB)

10

500

28/60


2333

2333

HAIC - MuGSI Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL)

10

1104

28/60


5152

5152

HAIC - Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form

10

340


28/60



1587

1587

HAIC - Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form

10

584


28/60



2725

2725

HAIC - CDI Case Report and Treatment Form

10

1650

38/60


10450

10450

HAIC Candidemia Case Report

10

170

40/60


1134

1134

HAIC- Annual Survey of Laboratory Testing Practices for C. difficile Infections.

10

16

15/60

19/60

40

51

HAIC- CDI Annual Surveillance Officers Survey

10

1

15/60


3

3

HAIC- Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey (LTCF)

10

45

5/60


38

38

HAIC- Invasive Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplification Testing (NAAT)

10

11

20/60


37

37

HAIC- Invasive Staphylococcus aureus Supplemental Surveillance Officers Survey

10

1

10/60


17

17

HAIC- Laboratory Testing Practices for Candidemia Questionnaire

10

20

11/60


37

37

TOTAL



38,883

38,894









File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleOMB CY 08
Authorwsb2
File Modified0000-00-00
File Created2021-01-12

© 2024 OMB.report | Privacy Policy